MedPath

Comparison between intraperitoneal ropivacaine alone and with Dexmedetomidine in laproscopic cholecystectomy

Not Applicable
Completed
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2019/03/017963
Lead Sponsor
Jln medical college Ajmer
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

1.Age group between 18 years to 60 years of both sex undergoing laparascopic cholecystectomy.

2.Patients belonging to ASA (American Society of Anaesthesiologists) grade-I and grade-II.

3.Gall Bladder calculi or polyp with no evidence of acute cholecystitis at the time of surgery.

Exclusion Criteria

1.Age less than 18 year of age or more than 60 year of age

2.ASA grade III or more (American Society of Anaesthesiology)

3.Pregnancy

4.Acute Cholecystitis

5.Choledocolithiasis

6.Conversion of laparascopic cholecystectomy to open cholecystectomy.

7.patient who are allergic study drug,severe cardiac disease ,pulmonary disease, neurological disease

patients in whom abdominal drain was put

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The intensity of postâ??operative pain was recorded for all the cases using VAS score after surgery <br/ ><br>Comaprison of effect in the patients between ropivacine alone and ropivacine with dexmedetomidineTimepoint: Duration of the study is around 1 year
Secondary Outcome Measures
NameTimeMethod
Total amount of rescue analgesic in 24 hours <br/ ><br>Haemodynamic change <br/ ><br>Any side effectsTimepoint: Duration of study around 1 year.
© Copyright 2025. All Rights Reserved by MedPath